Show simple item record

dc.contributor.authorGOMEZ-REINO, J. J.
dc.contributor.authorGül, Ahmet
dc.contributor.authorCARDIEL, M. H.
dc.contributor.authorTANAKA, Y.
dc.contributor.authorKWOK, K.
dc.contributor.authorLUKIC, T.
dc.contributor.authorMORTENSEN, E.
dc.contributor.authorPONCE DE LEON, D.
dc.contributor.authorRIESE, R.
dc.contributor.authorVALDEZ, H.
dc.contributor.authorWINTHROP, K. L.
dc.contributor.authorPARK, S-H
dc.date.accessioned2021-03-03T13:09:46Z
dc.date.available2021-03-03T13:09:46Z
dc.date.issued2016
dc.identifier.citationWINTHROP K. L. , PARK S., Gül A., CARDIEL M. H. , GOMEZ-REINO J. J. , TANAKA Y., KWOK K., LUKIC T., MORTENSEN E., PONCE DE LEON D., et al., "Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis", ANNALS OF THE RHEUMATIC DISEASES, cilt.75, sa.6, ss.1133-1138, 2016
dc.identifier.issn0003-4967
dc.identifier.othervv_1032021
dc.identifier.otherav_325752ed-d92a-48ef-8eae-30eacb98fb8b
dc.identifier.urihttp://hdl.handle.net/20.500.12627/38190
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2015-207319
dc.description.abstractObjectives To evaluate the risk of opportunistic infections (OIs) in patients with rheumatoid arthritis (RA) treated with tofacitinib.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectİmmünoloji ve Romatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleTuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis
dc.typeMakale
dc.relation.journalANNALS OF THE RHEUMATIC DISEASES
dc.contributor.department, ,
dc.identifier.volume75
dc.identifier.issue6
dc.identifier.startpage1133
dc.identifier.endpage1138
dc.contributor.firstauthorID51457


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record